International audience
-
August 22, 2017 (v1)Journal articleUploaded on: December 4, 2022
-
2017 (v1)Journal article
miR-34/449 microRNAs are conserved regulators of multiciliated cell differentiation. Here, we evidence and characterize expression of two isomiR variant sequences from the miR-34/449 family in human airway epithelial cells. These isomiRs differ from their canonical counterparts miR-34b and miR-449c by one supplemental uridine at their 5 0-end,...
Uploaded on: December 4, 2022 -
March 13, 2017 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
2017 (v1)Journal article
miR-34/449 microRNAs are conserved regulators of multiciliated cell differentiation. Here, we evidence and characterize expression of two isomiR variant sequences from the miR-34/449 family in human airway epithelial cells. These isomiRs differ from their canonical counterparts miR-34b and miR-449c by one supplemental uridine at their 5 0-end,...
Uploaded on: February 22, 2023 -
April 20, 2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
April 20, 2018 (v1)Journal article
International audience
Uploaded on: February 22, 2023 -
August 22, 2017 (v1)Journal article
Extracellular vesicles (EVs) have been shown to play an important role in intercellular communication as carriers of DNA, RNA and proteins. While the intercellular transfer of miRNA through EVs has been extensively studied, the stability of extracellular miRNA (ex-miRNA) once engulfed by a recipient cell remains to be determined. Here, we...
Uploaded on: December 4, 2022 -
September 30, 2014 (v1)Journal article
One of the earliest events in epithelial carcinogenesis is the dissolution of tight junctions and cell polarity signals that are essential for normal epithelial barrier function. Here, we report that EFA6B, a guanine nucleotide exchange factor for the Ras superfamily protein Arf6 that helps assemble and stabilize tight junction, is required to...
Uploaded on: December 3, 2022 -
May 2018 (v1)Journal article
Melanoma is one of the most lethal cancers when it reaches a metastatic stage. Despite advancements in targeted therapies (BRAF inhibitors) or immunotherapies (anti-CTLA-4 or anti-PD1), most patients with melanoma will need additional treatment. Thus, there is an urgent need to develop new therapeutical approaches to bypass resistance and...
Uploaded on: December 4, 2022 -
May 24, 2016 (v1)Journal article
International audience
Uploaded on: December 4, 2022